|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-7-16
|
|
pubmed:abstractText |
CD163 is a hemoglobin scavenger receptor exclusively expressed in the monocyte-macrophage system and its soluble form (sCD163) has not yet been studied as a serum marker in women with endometriosis. The purpose of this study was to evaluate whether serum levels of sCD163 and interleukin-6 (IL-6) could be possible markers for ovarian endometriomas discriminating adnexal benign cystic tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1423-002X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
66
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
47-52
|
|
pubmed:meshHeading |
pubmed-meshheading:18311079-Adult,
pubmed-meshheading:18311079-Antigens, CD,
pubmed-meshheading:18311079-Antigens, Differentiation, Myelomonocytic,
pubmed-meshheading:18311079-Biological Markers,
pubmed-meshheading:18311079-CA-125 Antigen,
pubmed-meshheading:18311079-Endometriosis,
pubmed-meshheading:18311079-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18311079-Female,
pubmed-meshheading:18311079-Humans,
pubmed-meshheading:18311079-Interleukin-16,
pubmed-meshheading:18311079-Middle Aged,
pubmed-meshheading:18311079-Ovarian Diseases,
pubmed-meshheading:18311079-Receptors, Cell Surface
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.
|
|
pubmed:publicationType |
Journal Article
|
